Chemical mutagenesis of the mouse is ongoing in several centers around the world, with varying estimates of mutation rate and number of sites mutable to phenotype. To address these questions, we sequenced ‫6.9ف‬ Mb of DNA from G 1 progeny of ethylnitrosourea-treated mice in a large, broad-spectrum screen. We identified 10 mutations at eight unique sites, including six nonsynonymous coding substitutions. This calibrates the nucleotide mutation rate for two mutagenesis centers, implies significance criteria for positional cloning efforts, and provides working estimates of effective genetic target sizes for selected phenotypes.
M
UTAGENESIS experiments provide both novel direct measurement of the nucleotide substitution rate (Beier 2000; Kile et al. 2003) . In particular, comparison mutations for biological studies and the means to estimate genomic parameters of the traits under of the nucleotide change rate to the rate of recovered phenotypic deviants should allow calculation of the efstudy. For example, the effective number of genes or the genome-wide target size for a particular phenotypic fective genome target size mutable to a given phenotype, without making assumptions about the distribution of muclass are of interest both for understanding the genetic architecture of a trait and for assessing the saturation table sites among distinct genes. Direct ascertainment of induced nucleotide changes also provides immediate acof mutable sites within a given screen. Estimates of these parameters depend on knowing the mutation rate cess to mutations of potential biological interest. Accurate measurement of the substitution rate is additionally within the experiment. Mutation rates, first defined by Muller, classically have been estimated by specific locus useful in evaluating candidate polymorphisms in positional cloning efforts. Brown and colleagues have pretests for failure to complement phenotype of a known mutation (Muller 1928; Russell 1951; Russell and viously estimated the rate of nucleotide change in a large chemical mutagenesis using heteroduplex detection by Montgomery 1982). Such estimates can be biased by the nature of the chosen gene (or genes) and the generdenaturing HPLC as a surrogate for sequence (Coghill et al. 2002) . These results may be difficult to apply more ality of phenotypes caused by its mutation. Inferring the nucleotide substitution rate from specific locus data generally because few mutations were observed (and the detection rate was not established), the potential therefore requires assumptions about the fraction of sites mutable to the tested phenotype and is open to subbias from sampling only three loci is unclear, and the mutagenesis protocol and strain choice are substantially stantial locus-specific bias. For many applications, the specific locus mutation rate is a sufficient term by itself, different from those used in other centers. Here we use DNA sequencing at 84 sentinel sites across 51 autosomal irrespective of the underlying nucleotide change rate. Indeed, classical estimates of genetic target size for a genes to identify 10 mutations in mice generated by a protocol shared by several mouse mutagenesis centers. phenotype and saturation level have focused on preIn addition to identifying potential functional mutations dicting gene number from the Poisson distribution and de novo, this work provides calibration of the nucleotide the frequency of induced alleles at known loci (Muller mutation rate averaged over a substantial number of and Prokofyeva 1935; Horowitz and Leupold 1951), individuals and genes for a mutagenesis protocol used but this requires the assumption that the subject genes by several U.S. centers. are equally mutable.
Several genomic applications would benefit from a After recovering fertility, ENU-treated males (G 0 ) were bred to coisogenic females to produce G 1 offspring that would be obligate heterozygotes for transmitted mutations and have the maximum point mutation density in somatic cells of any generation derived from these screens. Estimating the probability of recovering homozygotes: The probability of recovering a homozygote for a specific mutation in the G 3 generation was calculated from the average litter sizes at each generation. An average of 2.8 G 2 females were backcrossed to each G 1 male, with an average of 6.25 progeny/ G 1 ϫ G 2 pair. Thus the average probability of at least one G 3 homozygote, given heterozygosity of the G 2 mother, is:
where m is the mean G 3 number for each G 2 . For m ϭ 6.25, this is 0.834.
Since the probability of heterozygosity for a particular G 2 , given heterozygosity of her sire, is 0.5, the average probability of a G 1 mutation being homozygous in G 3 from a single G 2 partner is
Thus, the average probability for homozygosity with respect Figure 1 .-Mutagenesis and breeding. C57BL/6J male to a G 1 mutation in the G 3 derived from multiple G 2 partmice (G 0 ) were injected with ENU to induce mutations in ners is spermatogonia. Gametes carrying mutations (small asterisks) were recovered by breeding G 0 males to C57BL/6J females
. Progeny males (G 1 ) will be heterozygous for any transmitted mutations (large asterisk). G 1 males were bred to B6 where n is the mean number of G 2 partners. This reduces to females and their tail biopsies were screened for mutations the regular expression:
by DNA sequencing. G 3 progeny derived by backcross of G 2 females with their G 1 sires were ascertained for neurological
phenotypes. G 3 litters from a given G 1 include heterozygotes For m ϭ 6.25 and n ϭ 2.8, this is 0.779. and homozygotes (double asterisk) for transmitted viable muTo confirm the accuracy of this statistical distribution, we tations. also compared this estimated probability with the exact probability in each pedigree for the first 200 pedigrees. The comparison suggests that the calculation based on averages may overesbetween the two species. Collected sequences were aligned timate the number of homozygous mutations sampled among using a ClustalW (http:/ /www.ebi.ac.uk/clustalw/#). the G 3 by ‫.%7ف‬
Target selection and resequencing: Exons were selected from GenBank records or draft mouse genome assembly RESULTS (http:/ /genome.ucsc.edu) on the basis of size and relevance to neuronal signaling or gene regulation. Flanking primers prehensively analyzed for more detailed neurological ear phenotypes and 11 gait abnormalities. To date, 65 amino acid substitutions in the encoded protein ( Figure  3 ). To ask whether the missense mutations are likely to lines identified by phenotype have been made available from the screen reported here and its continuation alter function of the encoded protein, we performed a phylogenetic analysis of local sequence conservation (http://nmf.jax.org/, including phenotypes not of central interest to this center), with Ͼ100 additional lines around the mutated site. BLAST and translated BLAST searches of public databases were used to identify likely presently under development.
Calibration of nucleotide substitution rate: To proorthologs from several taxa. Reciprocal BLAST searches with these candidate sequences against the mouse gevide a more rigorous measure of nucleotide mutation rate in current mouse mutagenesis centers, we directly nome (and conservation of synteny where available) were used to confirm orthology. Presumptive orthologous sesequenced PCR products to identify de novo mutations in DNA from G 1 male progeny of ENU-treated C57BL/ quences were aligned using ClustalW (http:/ /www.ebi. ac.uk/clustalw/#). Three of the six mutations encode 6J mice using assays distributed across the genome (Figure 2) . To maximize the efficiency of a sequence-based nonconservative changes at conserved sites, including charge replacements in the encoded residue, suggesting screen, we selected mostly large exons among G-proteincoupled receptors and other genes of potential interest a higher likelihood of functional variation. Calculation of genetic target sizes: Calibration of the to the neuroscience community (Table S1 at http:/ /www. genetics.org/supplemental/). Analysis of 9.6 Mb of senucleotide change rate allows the calculation of the effective genetic target size for observed phenotype classes quence, including 84 assays from 51 genes in up to 510 G 1 mice, identified 10 nucleotide substitutions, defining (Table 1) . Taking the euchromatic genome as 2.49 ϫ 10 9 bp, of which 2.35 ϫ 10 9 bp is present in the autosomes a nucleotide mutation rate of 1.04 ϫ 10
Ϫ6
. As an estimate of data quality, the distribution of phred Q scores is shown (Waterston et al. 2002) , and the nucleotide substitution rate as 1.04 ϫ 10
, then ‫0052ف‬ de novo substitutions in Figure 2B and listed in Table S1 at http:/ /www.genetics. org/supplemental/. Each mutation was confirmed by should be present per G 1 male. Approximately 80% of G 1 substitutions should be observed at least once among sequencing both strands of a second amplification product from the same animal. Two substitutions were pres-G 3 offspring (or slightly less, to account for those linked to induced recessive lethal mutations), so among the ent in duplicate, indicating transmission of a premeiotic mutation to independent G 1 animals for a total of eight 1036 pedigrees ‫40.2ف‬ ϫ 10 6 de novo mutations should be represented by homozygotes. Therefore, one may unique mutations. Identical mutations in sibling G 1 animals reflect the limited number of premeiotic spermatoestimate the effective fraction of mutations corresponding to the six observed inner ear defects and 11 gait gonial stem cells that contribute to mature sperm in heavily mutagenized G 0 males (Noveroske et al. 2000) ataxias as ‫000,043/1ف‬ and 1/185,000 substitutions, respectively. and indicates, very approximately, 20% redundancy in the chromosomes screened.
This predicts a small genomic footprint for single base pairs mutable to each phenotype. Assuming no systematic Of eight unique mutations recovered, six predict bias in accessible sites, this would indicate effective target functional variation is much less. Only ‫%5ف‬ of the mouse genome is thought to be under purifying selecsizes for ENU mutagenesis of ‫0096ف‬ bp for inner ear and 12,700 bp for ataxia. To account for degenerate tion (Waterston et al. 2002) . Thus if the apparently functional (expressed, conserved, and known or presites, we used reported mammalian codon frequencies (Zeeberg 2002) to calculate the average degeneracy of dicted regulatory) sequences in a positional cloning interval are ascertained and only one nucleotide change A•T or G•C positions in coding sequences corrected for reported mammalian codon frequencies (approximately is observed, it may be appropriate to infer causation on the basis of resequencing alone with confidence levels twofold degeneracy on average; see Table S2 at http:/ /www. genetics.org/supplemental/). Extending this correction comparable to the traditional 0.05 significance level for single hypothesis tests. Consistent with this prediction, (as an estimate) to all mutable sites predicts ‫004,01ف‬ sites mutable to inner ear phenotypes by single base change sequencing all known positional candidate genes (annotated transcripts or predicted transcripts with at least and ‫050,91ف‬ sites similarly mutable to ataxia. Correction for the known repair-dependent bias of ENU for one EST in mouse or the corresponding region of humans) in a 1.7-Mb interval around a phenotypic muta-A•T base pairs (82% of transmitted mutations; pooling data from Noveroske et al. 2000; Coghill et al. 2002;  tion from this screen (Nmf9) identified a single base change (B. A. Hamilton, unpublished results). and the present study) does not significantly change these estimates based on a composite average.
Rate of closely linked, confounding mutations in clon-

DISCUSSION
ing projects: The nucleotide mutation rate also provides a substantial advantage in evaluating candidate mutaWe have applied independent measures of nucleotide tions in subsequent positional cloning efforts. Using and phenotypic mutation rates to estimate the effective the average rate of 1.04 ϫ 10 Ϫ6 defined here, one may target size for distinct phenotypic domains. We have calculate the probability of an uncharacterized or conlimited this calculation to fairly broad phenotypes, so founding mutation as a function of interval size. A nuclethat sufficient numbers of mutants will have been recovotide substitution should occur in a block of 50 kb Ͻ5% ered to make quantitatively accurate estimates, but in principle this could be extended to other phenotypes. of the time (Figure 4 ). More importantly, the rate of guanine phosphoribosyltransferase in human primary lymphocytes (Podlutsky et al. 1998) . Given some assumptions about the average mutable target size of a gene, the calculations provided here in turn may allow a rough estimate of the number of genes at an earlier stage in a screen than can be done from applying standard calculations based on multiple alleles identified in a specific locus test.
Our results define a rate of 1.04 ϫ 10 Ϫ6 mutations per nucleotide, or approximately one substitution per megabase (95% confidence interval, 5.0 ϫ 10 Ϫ7 -1.9 ϫ 10
Ϫ6
). The rate should apply to the coisogenic C57BL/6J screens conducted at both the Neuroscience Mutagenesis Facility (http://nmf.jax.org/) and the Mouse Heart, Lung, Blood and Sleep Disorders Center (http://pga. jax.org/) at the Jackson Laboratory, which used the same strain and protocol at the same site and likely extends to other programs that use a similar protocol in this strain, including centers at Baylor College of Medicine (Kile et al. 2003) and Northwestern University (S. Siepka and J. S. Takahashi, personal communication). Other approaches to chemical mutagenesis in the sequence in three assayed genes (Coghill et al. 2002) using a single dose protocol in a different mouse strain. Although the limited sample size also limits the statistiAlthough these phenotypes can be produced by mutacal significance of the difference in rate, the differences tions in several dozens of genes, the simple calculation in protocol and ascertainment methods suggest that the of mutable sites for two phenotype classes predicts only nominal rate differences may be real. As Coghill et al. several kilobases of target DNA. It is possible that linkage (2002) point out, ascertainment rates using surrogate to newly induced lethal mutations could reduce the assays can be difficult to verify and control. The differaverage probability of observing homozygotes for pheences in mouse strain and ENU dosing would also be notypic sites. Lethal mutations are the most frequent likely to contribute a real difference in rate of mutageneclass in mouse, as in other animals; however, this resis. Additionally, the small genomic footprint surveyed mains a small fraction of chromosomes (Kile et al. in that screen may show bias relative to other sites in the 2003). It is therefore unlikely to skew the rate of homozygenome compared with the broader footprint reported gosity for other mutations enough to greatly affect our
here. An alternative approach, chemical mutagenesis in calculation of target size (as long as the distribution of embryonic stem (ES) cells, has been reported to pro-G 1 nucleotide changes is not clustered). It is also possiduce an approximately twofold higher mutation rate ble that small target sizes are a statistical anomaly, as (Chen et al. 2000; Vivian et al. 2002) in four genes the calculations here are based on relatively modest surveyed and shows a different spectrum of base substinumbers of events and the variance on these measures tutions (by manipulating repair pathways), but requires may be substantial. Even taken together, however, these additional steps to produce mice for phenotyping. potential confounders are unlikely to account for more Forward genetic screens for disease-related or other than a fewfold underestimation. Most likely, this reflects biologically interesting phenotypes continue to identify the conservative nature of the codon table and of proand annotate new genes in mammalian biology. Comtein structures as well. Although the small genomic footplementary molecular screens add value both in providprint that we estimate does not necessarily limit the ing parametric measure for the density and effectiveness number of genes included in the mutable set, such of a given screen and in providing direct ascertainment nucleotide-level calculation underscores differences beof potential functional variants in genes of interest (Chen tween molecular and functional mutation rates. Munroe et al. 2000) . The falling marginal cost limited footprint calculated in our broad screen is conof DNA sequencing implies that high-throughput sesistent with the limited mutational spectrum found quencing applied to mutagenesis will be a competitive among somatic mutations selected for loss of p53 in human tumors (Hollstein et al. 1999) or hypoxanthine strategy for routinely identifying functional mutations
